Intermediate phenotypes underlying osteosarcoma risk
Intermediate phenotypes underlying osteosarcoma risk |
|
https://doi.org/10.18632/oncotarget.26476
Eleanor C. Semmes,
Chenan Zhang,
and Kyle M. Walsh
|
| 37345-37346 |
UBE2N plays a pivotal role in maintaining melanoma malignancy
UBE2N plays a pivotal role in maintaining melanoma malignancy |
|
https://doi.org/10.18632/oncotarget.26482
Anushka Dikshit,
and Jennifer Y. Zhang
|
| 37347-37348 |
Targeting hyaluronan accumulation in the tumor microenvironment
Targeting hyaluronan accumulation in the tumor microenvironment |
|
https://doi.org/10.18632/oncotarget.26483
Xiaoming Li,
and Curtis B. Thompson
|
| 37349-37351 |
CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition
CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition |
|
https://doi.org/10.18632/oncotarget.26424
Priya K. Gopalan,
Andres Gordillo Villegas,
Chunxia Cao,
Mary Pinder-Schenck,
Alberto Chiappori,
Wei Hou,
Maria Zajac-Kaye,
Alison M. Ivey,
and Frederic J. Kaye
|
| 37352-37366 |
Anti-claudin-4 extracellular domain antibody enhances the antitumoral effects of chemotherapeutic and antibody drugs in colorectal cancer
Anti-claudin-4 extracellular domain antibody enhances the antitumoral effects of chemotherapeutic and antibody drugs in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.26427
Rina Fujiwara-Tani,
Takamitsu Sasaki,
Yi Luo,
Kei Goto,
Isao Kawahara,
Yukiko Nishiguchi,
Shingo Kishi,
Shiori Mori,
Hitoshi Ohmori,
Masuo Kondoh,
and Hiroki Kuniyasu
|
| 37367-37378 |
MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule
MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule |
|
https://doi.org/10.18632/oncotarget.26436
Felix Grabenbauer,
Astrid Katzer,
Dmitri Sisario,
Simon Memmel,
Michael Flentje,
Vladimir L. Sukhoruko,
and Cholpon S. Djuzenova
|
| 37379-37392 |
EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR
EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR |
|
https://doi.org/10.18632/oncotarget.26446
Jordan Madic,
Cécile Jovelet,
Julien Lopez,
Barbara André,
Jean Fatien,
Isabelle Miran,
Aurélie Honoré,
Laura Mezquita,
Benjamin Besse,
Ludovic Lacroix,
and Magali Droniou
|
| 37393-37406 |
Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy
Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy |
|
https://doi.org/10.18632/oncotarget.26448
Charu Kothari,
Geneviève Ouellette,
Yvan Labrie,
Simon Jacob,
Caroline Diorio,
and Francine Durocher
|
| 37407-37420 |
Anti-C1-inactivator treatment of glioblastoma
Anti-C1-inactivator treatment of glioblastoma |
|
https://doi.org/10.18632/oncotarget.26456
Karolina Förnvik,
Jonatan Ahlstedt,
Kurt Osther,
Leif G. Salford,
and Henrietta Nittby Redebrandt
|
| 37421-37428 |
KLHL5 knockdown increases cellular sensitivity to anticancer drugs
KLHL5 knockdown increases cellular sensitivity to anticancer drugs |
|
https://doi.org/10.18632/oncotarget.26462
Robert J. Schleifer,
Shuchun Li,
Wyatt Nechtman,
Eric Miller,
Shan Bai,
Ashok Sharma,
and Jin-Xiong She
|
| 37429-37438 |
Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer
Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer |
|
https://doi.org/10.18632/oncotarget.26473
Jayati Chakrabarti,
Loryn Holokai,
LiJyun Syu,
Nina G. Steele,
Julie Chang,
Jiang Wang,
Syed Ahmed,
Andrzej Dlugosz,
and Yana Zavros
|
| 37439-37457 |
